1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Artificial Cornea and Corneal Implant Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Human Cornea
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Artificial Cornea
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Transplant Type
7.1 Penetrating Keratoplasty
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Endothelial Keratoplasty
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Anterior Lamellar Keratoplasty
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Keratoprosthesis
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Disease Indication
8.1 Fuchs’ Dystrophy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Fungal Keratitis
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Keratoconus
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Ambulatory Surgical Centers
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Specialty Clinics
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Advancing Sight Network
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 AJL Ophthalmic S.A.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Aurolab
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Corneat Vision Ltd
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 EyeYon Medical
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Florida Lions Eye Bank
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Keramed Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 L V Prasad Eye Institute
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 LinkoCare Life Sciences AB
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Mediphacos
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Presbia PLC
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 San Diego Eye Bank
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
世界の人工角膜・角膜移植市場予測2023年-2028年 |
| 【英語タイトル】Artificial Cornea and Corneal Implant Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 | |
 | ・商品コード：IMARC23FB0133 ・発行会社（調査会社）：IMARC ・発行日：2023年2月1日 ・ページ数：145 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール ・調査対象地域：グローバル ・産業分野：医療 |
| Single User | USD2,999 ⇒換算￥455,848 | 見積依頼/購入/質問フォーム |
| Five User | USD3,999 ⇒換算￥607,848 | 見積依頼/購入/質問フォーム |
| Enterprisewide | USD4,999 ⇒換算￥759,848 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| IMARC社は、2022年に412.5百万ドルであった世界の人工角膜・角膜移植市場規模が2028年に612.1百万ドルに達し、2023年から2028年の間に年平均6.5％成長すると予測しています。本調査レポートでは、人工角膜・角膜移植の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（ヒト角膜、人工角膜）分析、移植種類別（透過型角膜移植術、角膜内皮移植術、前部層状角膜移植術、人工角膜移植術）分析、疾患別（フックス角膜内皮変性症、真菌性角膜炎、円錐角膜、その他）分析、エンドユーザー別（病院、外来手術センター、専門診療所）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競合状況などの項目を掲載しています。また、本調査レポートに掲載されている企業情報には、Advancing Sight Network、AJL Ophthalmic S.A.、Aurolab、Corneat Vision Ltd、EyeYon Medical、Florida Lions Eye Bank、Keramed Inc.、L V Prasad Eye Institute、LinkoCare Life Sciences AB、Mediphacos、Presbia PLC and San Diego Eye Bank.などが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の人工角膜・角膜移植市場規模：種類別 - ヒト角膜の市場規模 - 人工角膜の市場規模 ・世界の人工角膜・角膜移植市場規模：移植種類別 - 透過型角膜移植術における市場規模 - 角膜内皮移植術における市場規模 - 前部層状角膜移植術における市場規模 - 人工角膜移植術における市場規模 ・世界の人工角膜・角膜移植市場規模：疾患別 - フックス角膜内皮変性症における市場規模 - 真菌性角膜炎における市場規模 - 円錐角膜における市場規模 - その他疾患における市場規模 ・世界の人工角膜・角膜移植市場規模：エンドユーザー別 - 病院における市場規模 - 外来手術センターにおける市場規模 - 専門診療所における市場規模 ・世界の人工角膜・角膜移植市場規模：地域別 - 北米の人工角膜・角膜移植市場規模 - アジア太平洋の人工角膜・角膜移植市場規模 - ヨーロッパの人工角膜・角膜移植市場規模 - 中南米の人工角膜・角膜移植市場規模 - 中東・アフリカの人工角膜・角膜移植市場規模 ・SWOT分析 ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競合状況 |
The global artificial cornea and corneal implant market size reached US$ 412.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 612.1 Million by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.
Artificial cornea and corneal implant refer to the surgical procedure conducted to replace parts of the damaged cornea with healthy corneal tissue obtained from a donor. The procedures are usually performed for the treatment of keratoconus, infectious keratitis, corneal ulcers and Fuchs dystrophy diseases. They include various medical procedures, such as penetrating and endothelial keratoplasty, that involve the transplantation of entire corneal stem cells. The implants are commonly available in synthetic and biosynthetic variants, which are manufactured using recombinant collagen and chemical substances. The implant procedures aid in restoring vision, relieving pain and treating damaged corneas. As a result, these procedures are widely conducted in hospitals and ophthalmic and ambulatory surgical centers (ASCs).
Artificial Cornea and Corneal Implant Market Trends:
The increasing prevalence of corneal infections and eye-related disorders among the masses is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Artificial cornea and corneal implant procedures are extensively used for the timely treatment of these disorders and the prevention of corneal blindness. Additionally, the increasing preference for penetrating keratoplasty procedures is favoring the market growth. These surgical procedures involve full-thickness corneal transplantation, which aids in treating ecstatic corneal diseases, such as keratoconus and pellucid marginal degeneration. Various product innovations, such as the development of three-dimensional (3D) printed artificial corneas with enhanced biocompatibility and customizability, are contributing to the market growth. In line with this, the increasing demand for artificial cornea and corneal implants to treat cloudy cornea caused by prolonged exposure to screen times is positively impacting the market growth. Other factors, including significant improvements in the healthcare infrastructure, along with the implementation of various government initiatives to prevent visual impairment among the masses, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial cornea and corneal implant market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, transplant type, disease indication and end user.
Breakup by Type:
Human Cornea
Artificial Cornea
Breakup by Transplant Type:
Penetrating Keratoplasty
Endothelial Keratoplasty
Anterior Lamellar Keratoplasty
Keratoprosthesis
Breakup by Disease Indication:
Fuchs’ Dystrophy
Fungal Keratitis
Keratoconus
Others
Breakup by End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advancing Sight Network, AJL Ophthalmic S.A., Aurolab, Corneat Vision Ltd, EyeYon Medical, Florida Lions Eye Bank, Keramed Inc., L V Prasad Eye Institute, LinkoCare Life Sciences AB, Mediphacos, Presbia PLC and San Diego Eye Bank.
Key Questions Answered in This Report
1. What was the size of the global artificial cornea and corneal implant market in 2022?
2. What is the expected growth rate of the global artificial cornea and corneal implant market during 2023-2028?
3. What are the key factors driving the global artificial cornea and corneal implant market?
4. What has been the impact of COVID-19 on the global artificial cornea and corneal implant market?
5. What is the breakup of the global artificial cornea and corneal implant market based on the type?
6. What is the breakup of the global artificial cornea and corneal implant market based on the transplant type?
7. What is the breakup of the global artificial cornea and corneal implant market based on the disease indication?
8. What is the breakup of the global artificial cornea and corneal implant market based on the end user?
9. What are the key regions in the global artificial cornea and corneal implant market?
10. Who are the key players/companies in the global artificial cornea and corneal implant market?
❖ レポートの目次 ❖
| ★調査レポート[世界の人工角膜・角膜移植市場予測2023年-2028年] (コード：IMARC23FB0133)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の人工角膜・角膜移植市場予測2023年-2028年]についてメールでお問い合わせ |
